US cuts $1.95 billion deal with Pfizer for 100 million doses of COVID-19 vaccine
Pfizer and BioNTech announced a $1.95 billion deal with the United States for pre-purchase of 100 million doses of an experimental vaccine candidate.
US cuts $1.95 billion deal with Pfizer for 100 million doses of COVID-19 vaccine
USATODAY.com
0 shares
1 views
You might like
Related news coverage
US sinks another $2.1 billion into a potential vaccine
SeattlePI.com
LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an..
-
Biggest coronavirus vaccine deal yet: $2.1 billion to Sanofi/GSK for up to 100 million doses
USATODAY.com
-
Sanofi, GlaxoSmithKline in $2.1 billion vaccine deal with U.S.
CBS News
-
GlaxoSmithKline, Sanofi get $2.1B to fund Covid-19 vaccine under Operation Warp Speed
bizjournals
-
Japan secures 120 mn doses of potential corona-vaccine: pharma group
IndiaTimes
Advertisement
More coverage
Is Coronavirus Vaccine Made From Fetal Cell Lines?
Eurasia Review
By Matt Hadro
As coronavirus vaccine prototypes move closer to testing and approval, some Catholics are debating the..
-
Canadian government has yet to place orders for leading potential COVID vaccines
National Post
-
Is the coronavirus vaccine made from fetal cell lines?
CNA
-
Adar Poonawalla: I believe Oxford coronavirus vaccine Covishield will reach masses by 2021 first quarter of
Mid-Day
-
"We have a winner": Trump administration inks $1.95-billion coronavirus vaccine deal, forcing taxpayers to enrich evil pharma giants
NaturalNews.com